GeneCode logo

GeneCode jobs and careers

Estonia

About GeneCode

GeneCode is developing small-molecule drugs that bind and activate GDNF (Glial cell line-Derived Neurotrophic Factor) receptors for the treatment of Parkinson’s disease (PD) and other neurodegenerative conditions.

Founded
1993
Employees
1 to 10
Total funding
$18M
Headquarters
Estonia